Sol-Gel Technologies (SLGL) Competitors $0.51 +0.02 (+4.08%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends SLGL vs. SYRS, STTK, MURA, CDTX, RPHM, KRON, IMRX, DTIL, SPRO, and BRNSShould you be buying Sol-Gel Technologies stock or one of its competitors? The main competitors of Sol-Gel Technologies include Syros Pharmaceuticals (SYRS), Shattuck Labs (STTK), Mural Oncology (MURA), Cidara Therapeutics (CDTX), Reneo Pharmaceuticals (RPHM), Kronos Bio (KRON), Immuneering (IMRX), Precision BioSciences (DTIL), Spero Therapeutics (SPRO), and Barinthus Biotherapeutics (BRNS). These companies are all part of the "pharmaceutical products" industry. Sol-Gel Technologies vs. Syros Pharmaceuticals Shattuck Labs Mural Oncology Cidara Therapeutics Reneo Pharmaceuticals Kronos Bio Immuneering Precision BioSciences Spero Therapeutics Barinthus Biotherapeutics Syros Pharmaceuticals (NASDAQ:SYRS) and Sol-Gel Technologies (NASDAQ:SLGL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings, community ranking and profitability. Which has more risk & volatility, SYRS or SLGL? Syros Pharmaceuticals has a beta of 1.59, meaning that its share price is 59% more volatile than the S&P 500. Comparatively, Sol-Gel Technologies has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500. Does the media refer more to SYRS or SLGL? In the previous week, Syros Pharmaceuticals had 11 more articles in the media than Sol-Gel Technologies. MarketBeat recorded 11 mentions for Syros Pharmaceuticals and 0 mentions for Sol-Gel Technologies. Syros Pharmaceuticals' average media sentiment score of 0.80 beat Sol-Gel Technologies' score of 0.00 indicating that Syros Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Syros Pharmaceuticals Positive Sol-Gel Technologies Neutral Is SYRS or SLGL more profitable? Syros Pharmaceuticals has a net margin of 0.00% compared to Sol-Gel Technologies' net margin of -227.40%. Sol-Gel Technologies' return on equity of -39.95% beat Syros Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Syros PharmaceuticalsN/A -1,419.05% -87.88% Sol-Gel Technologies -227.40%-39.95%-33.69% Which has better valuation & earnings, SYRS or SLGL? Sol-Gel Technologies has lower revenue, but higher earnings than Syros Pharmaceuticals. Sol-Gel Technologies is trading at a lower price-to-earnings ratio than Syros Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSyros Pharmaceuticals$9.94M6.11-$164.57M-$3.03-0.75Sol-Gel Technologies$1.55M9.17-$27.24M-$0.54-0.94 Do analysts recommend SYRS or SLGL? Syros Pharmaceuticals currently has a consensus price target of $5.00, indicating a potential upside of 120.75%. Sol-Gel Technologies has a consensus price target of $5.00, indicating a potential upside of 880.20%. Given Sol-Gel Technologies' higher probable upside, analysts plainly believe Sol-Gel Technologies is more favorable than Syros Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Syros Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Sol-Gel Technologies 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in SYRS or SLGL? Syros Pharmaceuticals received 218 more outperform votes than Sol-Gel Technologies when rated by MarketBeat users. Likewise, 64.05% of users gave Syros Pharmaceuticals an outperform vote while only 63.40% of users gave Sol-Gel Technologies an outperform vote. CompanyUnderperformOutperformSyros PharmaceuticalsOutperform Votes36764.05% Underperform Votes20635.95% Sol-Gel TechnologiesOutperform Votes14963.40% Underperform Votes8636.60% Do institutionals & insiders have more ownership in SYRS or SLGL? 91.5% of Syros Pharmaceuticals shares are held by institutional investors. Comparatively, 26.2% of Sol-Gel Technologies shares are held by institutional investors. 12.3% of Syros Pharmaceuticals shares are held by insiders. Comparatively, 66.5% of Sol-Gel Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummarySyros Pharmaceuticals beats Sol-Gel Technologies on 9 of the 17 factors compared between the two stocks. Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Get Sol-Gel Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SLGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLGL vs. The Competition Export to ExcelMetricSol-Gel TechnologiesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.21M$7.02B$5.40B$8.53BDividend YieldN/A7.96%5.15%4.14%P/E Ratio-0.949.36112.5515.07Price / Sales9.17386.151,478.8293.55Price / CashN/A47.3339.8334.04Price / Book0.315.324.645.01Net Income-$27.24M$153.56M$119.13M$225.46M7 Day Performance-21.99%0.12%0.78%0.37%1 Month Performance-21.66%15.23%5.65%3.57%1 Year Performance-59.19%41.16%36.90%29.42% Sol-Gel Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLGLSol-Gel Technologies2.4605 of 5 stars$0.51+4.1%$5.00+880.2%-60.8%$14.21M$1.55M-0.9450Gap UpSYRSSyros Pharmaceuticals4.6714 of 5 stars$2.40-5.1%$5.00+108.3%-5.2%$64.15M$4.15M-0.56120Earnings ReportAnalyst ForecastNews CoverageGap DownSTTKShattuck Labs3.5867 of 5 stars$1.33-0.7%$8.67+551.6%-22.4%$63.48M$4.12M-0.72100Gap DownMURAMural Oncology3.7954 of 5 stars$3.60+0.3%$16.00+344.4%N/A$61.34MN/A-0.35119CDTXCidara Therapeutics4.2839 of 5 stars$13.39+7.4%$29.67+121.6%-18.5%$61.09M$53.87M-0.5490Upcoming EarningsNews CoverageRPHMReneo Pharmaceuticals2.3163 of 5 stars$1.82+5.2%$11.01+505.1%-76.8%$60.84MN/A-0.8430Gap DownKRONKronos Bio3.5633 of 5 stars$1.00+1.7%$4.13+313.4%+17.4%$60.17M$8.41M-0.57100Short Interest ↓News CoverageIMRXImmuneering3.7702 of 5 stars$1.98flat$12.60+536.4%-71.1%$58.71M$320,000.00-1.0460Short Interest ↓News CoveragePositive NewsDTILPrecision BioSciences4.0207 of 5 stars$8.10-0.7%$39.50+387.7%-24.6%$58.60M$87.64M38.96200Upcoming EarningsSPROSpero Therapeutics4.5915 of 5 stars$1.07-18.3%$7.00+554.2%+3.5%$57.77M$105.43M3.2446News CoverageHigh Trading VolumeBRNSBarinthus Biotherapeutics3.48 of 5 stars$1.45+2.8%$5.83+302.3%N/A$57.16M$800,000.00-0.88107Short Interest ↓News Coverage Related Companies and Tools Related Companies Syros Pharmaceuticals Alternatives Shattuck Labs Alternatives Mural Oncology Alternatives Cidara Therapeutics Alternatives Reneo Pharmaceuticals Alternatives Kronos Bio Alternatives Immuneering Alternatives Precision BioSciences Alternatives Spero Therapeutics Alternatives Barinthus Biotherapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SLGL) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLGL Stock Alerts